In the preceding pages on the Biochemistry of Autism
and also on the Genetics of autism, a number of factors were identified, which
are associated with the development of Autism, and identification of such
factors may help it the treatment and prevention of the conditions. The
possibility exists that at some stage in development, all of these factors "come
together" at some point, and as such the condition has a much higher probability
of occurring if some or all of the factors are involved in a unique
developmentally important reaction or functional activity. Such a meeting point
would be regarded as a "Nexus". According to the "Nexus Theory™", proposed by Dr
Russell-Jones, the deficiencies outlined in the Biochemistry section of Wipe-Out
Autism, come together in a central point, vertix, or Nexus. This point of convergence
involves the final step in activation of the pro-hormone form of vitamin D (calcidiol,
25-hydroxy-vitamin D) to the biologically active form of vitamin D (calcitriol,
1,25-dihydroxy-vitamin D). This Nexus involves the interaction of three
different enzymes in a three
enzyme complex, CYP27B1 (25-hydroxyvitamin D3 1-alpha-hydroxylase), Adrenodoxin
(an Iron-sulphur protein) and Adrenodoxin reductase (an NADPH/.FAD enzyme). A
corollary of the theory is that a deficiency in the amount of 1, 25-dihydroxy
vitamin D in combination with the deficiencies that cause the vitamin D
deficiency dramatically affect the development of both the foetus and the
new-born child.
Clearly anything that reduces circulating amounts of 25-hydroxy
vitamin D, will have a direct impact on the ability of the fetus and newborn to
make the biologically active form of vitamin D, 1,25-dihydroxy vitamin D, and as
such will have an effect under the "Nexus Theory™". Hence the use of high SPF cosmetics by the mother
or gestation that is predominantly in the winter months, or basic lack of
sun-exposure of the mother during pregnancy, will reduce the circulating levels of vitamin D
of the mother, and hence the amount of vitamin D that gets to the foetus. In this regard,
the SPF value of women's cosmetics has increased from products with no added SPF
factors, to products now "boasting" SPF values over 60, over the past 20 or so
years, paralleling the increased rate of autism seen in the more affluent
countries, such as USA, UK, South Korea, and Australia.
Similarly mutations in the gene coding for the
Cytochrome P450 enzyme, CYP27B1
(the enzyme that "activates" vitamin D) could potentially reduce the rate and ability to convert what circulating 25-OHD
(calcidiol)
there is into the active form of the hormone, 1,25 DiOHD (Calcitriol). Such mutations are much more common in ASD individuals
than in the normal population, particularly rs4646536, rs703842, and rs10876994,
and would be more detrimental if multiple mutations are present in the gene (something
that is relatively common in ASD).
In addition, mutations in CYP24A1 that increase the inactivation of 1,25 diOHD
will also reduce the available vitamin. Slightly increased frequencies are seen
in the CYP24A1 variants, rs7975232 and rs2248359 in autistic individuals. Calcidiol =>
CYP27B1 - 25-hydroxyvitamin D3 1-alpha-hydroxylase
Note the Heme Structure in the
center of the enzyme
Low vitamin D has also been associated with increased
weight gain and diabetes, two common predisposing factors seen in mothers of
autistic children.
Adrenodoxin acts in concert with CYP27B1 in the
activation of vitamin D. The activity of the enzyme (Adrenodoxin) is helped by, and as such is dependent upon, the iron-sulphur
co-factor in the active site of the enzyme (see the cartoon below). Dissociation of iron-sulphur processes, such as those
found in Adrenodoxin, has been
observed when serum ferritin levels
drop below 70 ug/L. Low iron has been associated with delayed mental
development, and is commonly seen in autistic children, whose levels are commonly
found to be lower than those found in normally developing children. Generation of the sulphur atom in the iron-sulphur
protein comes with the movement of the sulphur, originally occurring in dietary
methionine into the sulphation cycle. Such movement, though, is dependent upon
generation of high levels of S-Adenosylmethionine, and as such, will be lower as
levels of active vitamin B12 decrease. Apart from its role in the generation of
iron-sulphur complexes, vitamin B12, through its role in methylation, also
controls the levels of CoQ10, creatine and ultimately acetylcholine, an
important neurotransmitter in the brain. A deficiency of vitamin B12 has also
been associated with delayed mental development. Lower vitamin B12 levels have
also been found in obesity and diabetes, two of the associative factors for
giving birth to a child with autism.
Adrenodoxin (also called Ferredoxin).
Note the Iron-sulphur cluster in the center of the molecule
Adrenodoxin acts together with Adrenodoxin reductase
in "helping" CYP27B1 to hydroxylate 25-hydroxy vitamin D and so form
1,25 dihydroxyD (Calcitriol). It's activity is
critically dependent upon two co-factors, one derived from vitamin B3 (NAPDH)
and the other from activation of vitamin B2 (FAD). As mentioned in the
Biochemistry section, production of FAD requires dietary vitamin B2, Iodine,
Selenium and Molybdenum, and so inadequate intake of these four nutrients can
lead to reduced production of FAD, with resultant reduction in activity of
Adrenodoxin reductase, and hence lower production of 1,25 Di-hydroxy vitamin D.
Insufficient Iodine is one of the two most easily preventable causes of mental
retardation in children. Recent studies in Boston have shown insufficient intake
of Iodine in over 50% of pregnant women admitted to maternity wards. Analysis of
the hair of ASD children has show that deficiencies in Selenium (80%) and Molybdenum (50%)
deficiency are very common. Reduced production of FMN and FAD from vitamin B2
eventually leads to obesity, due to the inability to burn fat, diabetes, due to
the inability to burn glucose for energy, and to a deficiency in vitamin B12,
due to lack of activity of methionine synthase reductase and
methylenetetrahydrofolate reductase. Hence the effect of low vitamin B2 would to
two fold, not only would it reduce the activity of Adrenodoxin reductase, but
though its affect on maintaining active B12 would also lead to less active
Adrenodoxin.
.
Adrenodoxin Reductase (also called Ferredoxin reductase).
Note the FAD molecule in the center of the enzyme
Apart from its known function in calcium metabolism
and bone metabolism, vitamin D (as 1,25-diOHD) ha been shown to be a potent "neurosteroid",
which plays a crucial role in the developing brain. Both CYP27B1 and CYP24A1
have been found in neural cells of the fetal brain indicating that the brain has
the potential to process "incoming" 25-hydroxy vitamin D, which has been formed
by the mother. Much lower levels of vitamin B12, which have been found in the
brains of children with autism, plus the lack of functional vitamin B2, would
mean that the ability of CYP27B1 to activate what little 25-hydroxy vitamin D is
present would be severely restricted, thus leading to poor neuronal development
typical of autism.
In addition to its direct role as a "neurosteroid" the
combination of low 1,25 dihydroxyvitamin B12, and the reduced capacity for
myelination that would occur due to lack of iron, and functional vitamin B12 and
vitamin B2, combined with reduced production of the neurotransmitters hydrogen
sulphide, acetyl choline, and the reduced mitochondrial energy production which
accompanies Iron/B12 and B2 deficiency, would more than readily explain the
delayed development that typifies autism. This would be further compromised by
the greatly reduced production of the developmentally important hormone, melatonin
that occurs
in vitamin B12 deficiency.
Recently melatonin has been shown to induce neuronal
stem cell differentiation into oligodendrocytes and neurons (Mendivinil etal,
2017), hence in B12 deficiency, with the resultant lower production of
melatonin, this would be compromised. This may also explain why there is a
reduction in the number of immature neurons in the amygdala region of the brain
in people with ASD (Avino etal (2018).
Myelination (addition of an insulatory "sheath" to
the nerves) is critically important for development of speech, cognition and
emotional development, and defects in myelination have been found not only in disorders
such as autism, but also in dyslexia and attention-deficit hyperactivity disorder.
Destruction of the myelin-sheath has also been found in Alzheimer's disease.
Production of the myelin sheath in the brain is dependent upon the action of a
specific cell, the oligodendrocyte, which produces the myelin layer that "wraps"
around the nerve. Myelination increases the "conduction" speed of nerves and
controls how they interact. Myelination of appropriate areas of the brain has
been correlated with the development of specific functions in the brain, such as
development of vocabulary, reading, and many cognitive tasks.
Vitamin D (as 1,25 dihydroxyvitamin D - the active
form) has a critical role in remyelination in damaged nerves and in the initial
myelination of nerves, and in the processes involved in "neuronal plasticity".
Oligodendrocytes (the cells that make the myelin sheath) are stimulated to
produce myelin by binding active vitamin D. The myelin sheath, so elicited is a
layered structure, that is composed of three main proteins, one of which is
myelin basic protein. The structure of myelin basic protein is critically
dependent upon methylation (and hence methyl B12) and in B12 deficiency
improperly folded MBP is formed and improper myelin sheath is developed. In
addition, in adenosylB12 deficiency, improper lipids are inserted into the
myelin sheath once again disrupting their structure.
In summary, the "Nexus Theory™" of Autism unites the
various theories of the delayed mental development seen in Autism and
encompasses the data on low Vitamin D, low iron, low vitamin B12, low vitamin
B2, low Iodine, low selenium and low molybdenum, and also the different rates of
expression of various genetic variants seen in autism. A real nature and nurture
combination. As such the condition would appear to be entirely preventable by
adequate nutrition in the mothers, and by maintaining sufficient vitamin D.
Potentially, by addressing the known metabolic deficiencies present in these
children, the condition could also be largely resolvable.
Further Applications: The "Nexus Theory™" has massive
implications for other neuronal conditions that involve neuronal signaling or
break-down, including MS, dementia, stroke, spinal chord injuries, brain
plasticity, etc, and may help to explain lack of progress in these areas and
provide potential areas of future research.
In 2018 the highest incidence of autism was in South
Korea with 1 in 30 children being diagnosed with autism. Examination of data on
vitamin B12, iron, vitamin B2 and vitamin D, strongly suggest that the Nexus
Theory™ would well apply.
Vitamin B12 deficiency is common in S. Korea, with
over 17% of S. Koreans having B12 levels of less than 125 pmol/L, and 36.2%
having between 125 to 250 pmol/L (Kim etal, 2018).
Studies on dietary intake of riboflavin has shown
that one-third of S. Korean adults has an inadequate riboflavin intake (Choi,
etal, 2015).
Iron deficiency is also common in S. Korea, with 33%
of Koreans 18-49 yo being iron deficient, as judged by ferritin below 15
ug/L, (for females, the mean ferritin in this age group was 30 ug/L, which is
below the mean in India) BUT, if one considers that you can see iron deficiency
metabolically when ferritin is below 70, this would mean that the vast majority
of women of child bearing ages would be iron deficient.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924001/
Adding to the picture, and completing the
requirements of Nexus Theory, in 2014, 82.5% of S. Korean females were deemed to
be vitamin D deficient (Park etal, 2018), an increase from 28.2% in 2008.
Ali, Asad, Cui, Xiaoying and Eyles, Darryl (2016).
Developmental vitamin D deficiency and autism: putative pathogenic mechanisms.
Journal of Steroid Biochemistry and Molecular Biology, .
doi:10.1016/j.jsbmb.2016.12.018
Vinkhuyzen, A. A. E., Eyles, D. W., Burne, T. H. J.,
Blanken, L. M. E., Kruithof, C. J., Verhulst, F., Jaddoe, V. W., Tiemeier, H.
and McGrath, J. J. (2016). Gestational vitamin D deficiency and autism-related
traits: the Generation R Study. Molecular Psychiatry, . doi:10.1038/mp.2016.213
Pertile, Renata A. N., Cui, Xiaoying and Eyles, Darryl W.
(2016). Vitamin D signaling and the differentiation of developing dopamine
systems. Neuroscience, 333 193–203. doi:10.1016/j.neuroscience.2016.07.02
Vuillermot, Stephanie, Luan, Wei, Meyer, Urs and Eyles,
Darryl (2017). Vitamin D treatment during pregnancy prevents autism-related
phenotypes in a mouse model of maternal immune activation. Molecular Autism, 8
1: . doi:10.1186/s13229-017-0125-0
Gazibara, Tatjana, Elbert, Niels J., den Dekker, Herman T.,
de Jongste, Johan C., Reiss, Irwin, McGrath, John J., Eyles, Darryl W., Burne,
Thomas H., Tiemeier, Henning, Jaddoe, Vincent W. V., Pasmans, Suzanne G. M. A.
and Duijts, Liesbeth (2016). Associations of maternal and fetal
25-hydroxyvitamin D levels with childhood eczema: The Generation R Study.
Pediatric Allergy and Immunology, 27 3: 283–289. doi:10.1111/pai.12530
Cairncross, Carolyn, Grant, Cameron, Stonehouse, Welma,
Conlon, Cath, McDonald, Barry, Houghton, Lisa, Eyles, Darryl, Camargo, Carlos
A., Coad, Jane and von Hurst, Pamela (2016). The relationship between vitamin D
status and allergic diseases in New Zealand preschool children. Nutrients, 8 6:
. doi:10.3390/nu8060326
Miliku, Kozeta, Vinkhuyzen, Anna, Blanken, Laura M. E.,
McGrath, John J., Eyles, Darryl W., Burne, Thomas H., Hofman, Albert, Tiemeier,
Henning, Steegers, Eric A. P., Gaillard, Romy and Jaddoe, Vincent W. V. (2016).
Maternal vitamin D concentrations during pregnancy, fetal growth patterns, and
risks of adverse birth outcomes. American Journal of Clinical Nutrition, 103 6:
1514–1522. doi:10.3945/ajcn.115.123752
Overeem, Kathie, Eyles, Darryl W., McGrath, John J. and
Burne, Thomas H. J. (2016). The impact of vitamin D deficiency on behaviour and
brain function in rodents. Current Opinion in Behavioral Sciences, 7 47–52.
doi:10.1016/j.cobeha.2015.11.012
Fernell, Elisabeth, Bejerot, Susanne, Westerlund, Joakim,
Miniscalco, Carmela, Simila, Henry, Eyles, Darryl, Gillberg, Christopher and
Humble, Mats B. (2015). Autism spectrum disorder and low vitamin D at birth: a
sibling control study. Molecular Autism, 6 1: 3.1–3.9. doi:10.1186/2040-2392-6-3
Turner, Karly M., Young, Jared W., McGrath, John J., Eyles,
Darryl W. and Burne, Thomas H. J. (2013). Cognitive performance and response
inhibition in developmentally vitamin D (DVD)-deficient rats. Behavioural Brain
Research, 242 1: 47–53. doi:10.1016/j.bbr.2012.12.029
Byrne, Jacqueline H., Voogt, Meggie, Turner, Karly M.,
Eyles, Darryl W., McGrath, John J. and Burne, Thomas H. J. (2013). The impact of
adult vitamin D deficiency on behaviour and brain function in male Sprague-Dawley
rats. PLoS ONE, 8 8: e71593.1–e71593.14. doi:10.1371/journal.pone.0071593
Eyles, D. W., Liu, P. Y., Josh, P. and Cui, X. (2014).
Intracellular distribution of the vitamin D receptor in the brain: Comparison
with classic target tissues and redistribution with development. Neuroscience,
268 1–9. doi:10.1016/j.neuroscience.2014.02.042
Snaidero, N. and Simons, M. 2014 Myelination at a glance.
www.jcs.biologists.org/content/joces/127/14/299.full.pdf
Mendivil etal, (2017) Melatonin enhances neural stem cell differentiation and
engraftment by increasing mitochondrial function. j. Pin. Res, 63
PMID29423196
Avino etal, (2018) Neuron numbers increase in the human amygdala from birth to
adulthood, but not in autism. PNAS
PMID29559529
Altun etal, 2018 The Levels of Vitamin D, Vitamin D Receptor, Homocysteine
and Complex B Vitamin in Children with Autism Spectrum Disorders. Clin
Psychopharmacol Neurosci. 2018 Nov 30;16(4):383-390. doi:
10.9758/cpn.2018.16.4.383.
Kim etal, 2018. One-half of Korean adults studied had marginal vitamin B12
status assessed by plasma vitamin B12. Nutr. Res. 50: 37-43
Choi etal, 2015 Evaluation of riboflavin intakes and status of 20-64 year old
adults in South Korea. Nutrients, 7, 253-264
Park etal, 2018 Vitamin D status in South Korean
population: Seven-year trend from the KNHANES
https://ncbi.nlm.nih.gov/pubmed/29952942
Special Thanks
Special thanks to
www.protopedia.org for the animated GIF
images.
Copyright © 2017
wipeoutautism.org. All Rights Reserved.
"Nexus Theory™"
Vitamin D and the
"Nexus Theory™"
Calcitriol
Adrenodoxin and the Nexus Theory™
Adrenodoxin Reductase and the Nexus
Theory™
Vitamin D, brain development and the
Nexus Theory™
South
Korea, autism and the Nexus Theory™
References/ Useful links.
The statements on this site compose a compendium of generally recognized signs
of Autism. They also are formulated from a summary of relevant
scientific publications. In addition they may contain some forward looking
statements of a general nature.
Reproduction in whole or in part in any form or medium without express written
permission is prohibited